EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte Studie

Effects of Lactocaseibacillus paracasei subsp. paracasei NTU 101 on gut microbiota: a randomized, double‐blind, placebo‐controlled clinical study

Tzu-Hsing Lin, Tsung-Wei Shih, Chih-Hui Lin iD

Journal of the Science of Food and Agriculture · 2024

DOI: 10.1002/jsfa.13772 ↗

At a glance

Randomisierte kontrollierte Studie in Journal of the Science of Food and Agriculture, 2024. Written by Tzu-Hsing Lin and 2 co-authors. Institution: Department of Life Science, National Taitung University, Taitung, Taiwan. Major MEDLINE topics: Gastrointestinal Microbiome, Probiotics, Feces, Lacticaseibacillus paracasei. Cited 3 times so far (Crossref); 43 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

BACKGROUND Lactocaseibacillus paracasei subsp. paracasei NTU 101 (NTU101) is a well‐known commercial probiotic with multiple health beneficial effects. In this study, the gut microbiota modulation effect of an NTU 101 product, Vigiis 101‐LAB, on healthy human was investigated in a randomized, double‐blind, placebo‐controlled human trial. RESULTS Vigiis 101‐LAB significantly modulated human gut microbiota at fourth and sixth weeks of trial (anosim analysis, P = 0.001). It also significantly improved peristalsis ( P = 0.003) and shortened defecation interval of subjects. The shift of gut microbiota is significantly fit with defecation interval ( P = 0.009) and stool shape ( P = 0.001) of subjects. CONCLUSION Our results suggest that Vigiis 101‐LAB promotes human intestinal health with improvement of peristalsis and fecal quality. The gut modulation effects of Vigiis 101‐LAB subsequently raised the abundance of vitamin B7, vitamin K, pyrimidine and purine biosynthesis pathways. Vigiis 101‐LAB may promote peristalsis via purinergic pathway and possibly conferring prophylactic benefits against irritable bowel syndrome with constipation. © 2024 Society of Chemical Industry.

Subjects

MeSH terms (MEDLINE)

Gastrointestinal MicrobiomeProbioticsFecesLacticaseibacillus paracaseiHumansMaleAdultFemaleDouble-Blind MethodYoung AdultBacteriaMiddle AgedDefecationConstipation

Author keywords

Lactcaseiobacillus paracasei subsp. paracasei NTU 101gut microbiotaperitalsis

Authors and institutions

  • Department of Life Science, National Taitung University, Taitung, Taiwan.
  • SunWay Biotech Ltd., Taipei, Taiwan.

ORCID profiles: Chih-Hui Lin

Cite

APA

Lin, T. H., Shih, T. W., & Lin, C. H. (2024). Effects of Lactocaseibacillus paracasei subsp. paracasei NTU 101 on gut microbiota: a randomized, double‐blind, placebo‐controlled clinical study. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.13772

Vancouver

Lin TH, Shih TW, Lin CH. Effects of Lactocaseibacillus paracasei subsp. paracasei NTU 101 on gut microbiota: a randomized, double‐blind, placebo‐controlled clinical study. Journal of the Science of Food and Agriculture. 2024. doi:10.1002/jsfa.13772

BibTeX
@article{Lin2024,
  author = {Lin, Tzu-Hsing and Shih, Tsung-Wei and Lin, Chih-Hui},
  title = {Effects of Lactocaseibacillus paracasei subsp. paracasei NTU 101 on gut microbiota: a randomized, double‐blind, placebo‐controlled clinical study},
  journal = {Journal of the Science of Food and Agriculture},
  year = {2024},
  doi = {10.1002/jsfa.13772}
}
Start for free →